Subscribe to our newsletter to receive the latest product updates and special offers

HomeNewsScreenerMapsGroupsPortfolioInsiderFuturesForexCryptoBacktestsElite
Theme 		Help
Order by Signal Tickers
Filters
Overview Valuation Financial Ownership Performance Technical ETF ETF Perf Custom Charts Tickers Basic TA News Snapshot Maps Stats
#191 / 200 Total
PTIX - Protagenic Therapeutics Inc - Stock Price Chart
TickerPTIX [NASD]
CompanyProtagenic Therapeutics Inc
CountryUSA
IndustryBiotechnology
Market Cap6.86MEPS (ttm)-1.37
P/E-EPS this Y-
Forward P/E-EPS next Y-
PEG-EPS past 5Y-2.91%
P/S-EPS next 5Y-
P/B3.21EPS Q/Q-133.79%
Dividend-Sales Q/Q-
Insider Own21.92%Inst Own8.08%
Insider Trans0.00%Inst Trans-1.78%
Short Float0.28%EarningsApr 01/a
Analyst Recom1.00Target Price16.00
Avg Volume17.30K52W Range0.68 - 2.23
May-22-24 08:12AM Protagenic Therapeutics' Stress-Regulating Peptide Demonstrates Exceptional Safety in Single Dose Portion of Phase I Trial, Paving the Way for Next Steps Toward Potential Breakthrough Treatments in Stress Related Neuropsychiatric Disorders (ACCESSWIRE) +12.60%
May-01-24 08:38AM Protagenic Therapeutics Completes Enrollment in Single Dose Portion of Phase 1 of Innovative Stress Disorder Trial (ACCESSWIRE) -5.58%
Apr-17-24 08:42AM Protagenic Therapeutics' Innovative Peptide PT00114 to be Highlighted at Boston Summit (ACCESSWIRE)
Apr-01-24 09:53PM PTIX Stock Earnings: Protagenic Therapeutics Reported Results for Q4 2023 (InvestorPlace)
04:20PM Protagenic Therapeutics Reports Fourth Quarter and Full Year 2023 Results (ACCESSWIRE)
Mar-27-24 08:42AM Protagenic Therapeutics Successfully Concludes Third Cohort in Single Dose Portion of Phase 1 Trial for Stress-Related Neuropsychiatric Disorders (ACCESSWIRE)
Mar-25-24 05:00PM Protagenic Therapeutics Schedules First Q4 and FY 2023 Earnings Call (ACCESSWIRE) +12.37%
Mar-21-24 08:41AM Protagenic Therapeutics Announces Resolution of Nasdaq Deficiency Notice (ACCESSWIRE) +5.93%
Feb-13-24 08:30AM Protagenic Therapeutics Achieves First Clinical Safety Milestone with its Novel Neuropeptide for the Potential Treatment of Stress-Related Disorders (ACCESSWIRE)
Dec-12-23 07:30AM Protagonist Reports 2-Year Follow Up Data from Rusfertide REVIVE Study at the ASH Annual Meeting Showing Durable Efficacy and No New Safety Signals (ACCESSWIRE) +15.65%
SMFL - Smart for Life Inc - Stock Price Chart
TickerSMFL [NASD]
CompanySmart for Life Inc
CountryUSA
IndustryPackaged Foods
Market Cap0.87MEPS (ttm)-1221.87
P/E-EPS this Y-
Forward P/E-EPS next Y-
PEG-EPS past 5Y-
P/S0.08EPS next 5Y-
P/B0.32EPS Q/Q76.01%
Dividend-Sales Q/Q-48.66%
Insider Own1.26%Inst Own7.83%
Insider Trans0.00%Inst Trans-99.70%
Short Float13.40%Earnings-
Analyst Recom3.00Target Price504.00
Avg Volume907.88K52W Range2.28 - 144.90
May-28-24 07:30PM Smart for Life Announces Updates on Successful Completion of Restructuring Program (GlobeNewswire) +9.12%
May-21-24 01:00PM Smart for Life to Attend the 2024 NASC Annual Conference (GlobeNewswire)
May-13-24 08:58AM Nano Hearing Aids Names Ryan Zackon as Chief Executive Officer (GlobeNewswire) -19.40%
May-10-24 08:00AM Smart for Life to Attend Vitafoods Europe 2024: Positioned to Identify Strategic Partnerships and Potential Acquisitions (GlobeNewswire) +8.77%
May-07-24 08:58AM ku and Inspired Specialty Products Inc. Appoint Consumer Industry Veteran Ryan F. Zackon as Co-Chair of the Board of Directors (GlobeNewswire) -5.64%
Apr-29-24 08:30AM Smart For Life to Attend National Pet Food Forum on April 29 to May 2 (GlobeNewswire)
Apr-26-24 08:00AM Smart for Life Announces Availability of a White Paper on the Nutraceuticals Industry (GlobeNewswire) +15.71%
Apr-24-24 08:30AM Smart for Life Appoints Prominent Industry Executive David Trosin to Company's Advisory Board (GlobeNewswire) -6.84%
Apr-23-24 05:30PM Smart for Life Announces the Successful Completion of Restructuring Program (GlobeNewswire) +7.59%
Apr-18-24 02:00PM Smart for Life Announces the Appointment of Heather Granato to the Company's Board of Directors (GlobeNewswire)
PRME - Prime Medicine Inc - Stock Price Chart
TickerPRME [NASD, RUT]
CompanyPrime Medicine Inc
CountryUSA
IndustryBiotechnology
Market Cap780.20MEPS (ttm)-2.13
P/E-EPS this Y25.01%
Forward P/E-EPS next Y7.56%
PEG-EPS past 5Y-193.88%
P/S1322.36EPS next 5Y-
P/B3.20EPS Q/Q0.97%
Dividend-Sales Q/Q-
Insider Own57.90%Inst Own34.64%
Insider Trans16.03%Inst Trans-
Short Float22.26%EarningsMay 10/b
Analyst Recom1.33Target Price14.18
Avg Volume763.29K52W Range4.11 - 17.20
Today 06:30AM If You Can Only Buy One Biotech Stock in May, It Better Be One of These 3 Names (InvestorPlace)
May-25-24 04:10AM Here Are the 2 Growth Stocks Google's Parent Company Just Added to Its $7 Billion Portfolio (Motley Fool)
May-20-24 09:32PM Cathie Wood Pulls the Trigger on These 2 Strong Buy Stocks (TipRanks) +6.36%
09:33AM HC Wainwright Starts Coverage on Prime Medicine With Buy Rating, $10 Price Target (MT Newswires)
May-17-24 06:27AM Wall Street Favorites: 3 Cathie Wood Stocks With Strong Buy Ratings for May 2024 (InvestorPlace)
06:15AM Wall Street Favorites: 3 Biotech Stocks with Strong Buy Ratings for May 2024 (InvestorPlace)
May-16-24 07:14AM Citigroup Upgrades Prime Medicine at Buy From Neutral With $10 Price Target (MT Newswires)
May-14-24 09:55AM Does Prime Medicine, Inc. (PRME) Have the Potential to Rally 133.64% as Wall Street Analysts Expect? (Zacks)
May-13-24 11:12AM JPMorgan Adjusts Price Target on Prime Medicine to $15 From $16, Keeps Overweight Rating (MT Newswires) +14.44%
08:00AM Prime Medicine to Present at H.C. Wainwright 2nd Annual BioConnect Investor Conference at NASDAQ (GlobeNewswire)
LNSR - LENSAR Inc - Stock Price Chart
TickerLNSR [NASD]
CompanyLENSAR Inc
CountryUSA
IndustryMedical Devices
Market Cap51.30MEPS (ttm)-1.13
P/E-EPS this Y22.52%
Forward P/E-EPS next Y16.75%
PEG-EPS past 5Y0.14%
P/S1.15EPS next 5Y-
P/B1.61EPS Q/Q52.50%
Dividend-Sales Q/Q28.31%
Insider Own21.73%Inst Own42.62%
Insider Trans0.00%Inst Trans-0.49%
Short Float0.92%EarningsMay 09/b
Analyst Recom1.00Target Price8.00
Avg Volume43.38K52W Range1.80 - 5.30
May-23-24 08:00AM LENSAR to Participate in the 2024 Leerink Partners Healthcare Crossroads Conference (Business Wire)
May-13-24 11:14AM LENSAR, Inc. (NASDAQ:LNSR) Q1 2024 Earnings Call Transcript (Insider Monkey)
May-09-24 11:57AM LNSR Stock Earnings: LENSAR Beats EPS, Beats Revenue for Q1 2024 (InvestorPlace) +12.68%
07:00AM LENSAR Reports First Quarter 2024 Results and Provides Business Update (Business Wire)
May-02-24 08:00AM LENSAR to Report First Quarter 2024 Financial Results on Thursday, May 9, 2024 (Business Wire)
May-01-24 06:38PM LENSAR Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) (Business Wire)
Apr-01-24 06:28PM LENSAR Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) (Business Wire)
Mar-05-24 09:11AM LENSAR, Inc. (NASDAQ:LNSR) Q4 2023 Earnings Call Transcript (Insider Monkey) -10.97%
Mar-04-24 07:00AM LENSAR Reports Fourth Quarter and Full Year 2023 Results and Provides Business Update (Business Wire)
Mar-01-24 05:01PM LENSAR Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) (Business Wire)
ULY - Urgent.ly Inc - Stock Price Chart
TickerULY [NASD]
CompanyUrgent.ly Inc
CountryUSA
IndustrySoftware - Application
Market Cap25.63MEPS (ttm)5.97
P/E0.32EPS this Y-110.96%
Forward P/E-EPS next Y76.26%
PEG-EPS past 5Y-
P/S0.15EPS next 5Y-
P/B-EPS Q/Q26.93%
Dividend-Sales Q/Q-19.13%
Insider Own17.20%Inst Own14.64%
Insider Trans-2.72%Inst Trans-
Short Float0.53%EarningsMay 13/a
Analyst Recom1.00Target Price5.00
Avg Volume51.47K52W Range1.47 - 12.00
May-14-24 03:06AM Urgently Inc (ULY) Q1 2024 Earnings Call Transcript Highlights: Navigating Challenges and ... (GuruFocus.com)
May-13-24 08:56PM ULY Stock Earnings: Urgently Misses EPS, Beats Revenue for Q1 2024 (InvestorPlace) -9.28%
04:05PM Urgently Announces First Quarter 2024 Financial Results (GlobeNewswire)
Apr-29-24 05:00PM Urgently Announces First Quarter 2024 Earnings Release Date and Conference Call; Participation in Upcoming Investor Conferences (GlobeNewswire)
Mar-14-24 04:00PM Urgently Announces Fourth Quarter and Full-Year 2023 Financial Results (GlobeNewswire)
Mar-11-24 09:00AM Urgently Announces Fourth Quarter and Full Year 2023 Earnings Release Date and Conference Call (GlobeNewswire)
Feb-26-24 06:00PM Urgently to Participate in Upcoming Investor Conferences (GlobeNewswire) +13.51%
Jan-22-24 08:00AM Urgently Secures Engagement with Global Top 5 Automotive OEM (GlobeNewswire)
Dec-05-23 10:25AM Sidoti Events, LLC's Virtual December Small-Cap Conference (ACCESSWIRE)
Nov-30-23 09:00AM Urgently to Participate in Upcoming Investor Conferences (Business Wire) +6.57%
SIFY - Sify Technologies Limited ADR - Stock Price Chart
TickerSIFY [NASD]
CompanySify Technologies Limited ADR
CountryIndia
IndustryTelecom Services
Market Cap307.99MEPS (ttm)-
P/E-EPS this Y-0.25%
Forward P/E42.02EPS next Y300.00%
PEG-EPS past 5Y-49.35%
P/S0.72EPS next 5Y-
P/B1.69EPS Q/Q-
Dividend-Sales Q/Q7.73%
Insider Own-Inst Own0.60%
Insider Trans-Inst Trans-13.59%
Short Float0.03%EarningsApr 22/a
Analyst Recom1.00Target Price3.93
Avg Volume108.67K52W Range1.16 - 3.37
May-21-24 04:00PM Sify Technologies Ltd. Announces Key Dates for Rights Offering (PR Newswire)
Apr-23-24 08:20AM Sify Technologies Limited (NASDAQ:SIFY) Q4 2024 Earnings Call Transcript (Insider Monkey)
Apr-22-24 03:22PM UPDATE: Sify reports Consolidated Financial Results for FY 2023-24 (GlobeNewswire)
02:52PM SIFY Stock Earnings: Sify Technologies Misses Revenue for Q4 2024 (InvestorPlace)
09:14AM Sify Technologies Q4 Profit Increases (RTT News)
08:00AM Sify reports Consolidated Financial Results for FY 2023-24 (GlobeNewswire)
Apr-15-24 09:01AM Sify Technologies to announce Financial Results for FY 2023-24 on April 22, 2024 (GlobeNewswire)
Mar-21-24 06:35PM Sify Technologies Ltd. Announces Plans for Rights Offering to Shareholders (PR Newswire)
Jan-22-24 01:51PM SIFY Stock Earnings: Sify Technologies Misses Revenue for Q3 2024 (InvestorPlace)
Jan-19-24 08:11AM Sify Technologies Limited (NASDAQ:SIFY) Q3 2024 Earnings Call Transcript (Insider Monkey)
LL - LL Flooring Holdings Inc - Stock Price Chart
TickerLL [NYSE]
CompanyLL Flooring Holdings Inc
CountryUSA
IndustryHome Improvement Retail
Market Cap49.98MEPS (ttm)-4.22
P/E-EPS this Y26.18%
Forward P/E-EPS next Y33.96%
PEG-EPS past 5Y-13.55%
P/S0.06EPS next 5Y30.00%
P/B0.37EPS Q/Q-172.00%
Dividend-Sales Q/Q-21.69%
Insider Own14.23%Inst Own38.13%
Insider Trans0.00%Inst Trans-12.73%
Short Float3.61%EarningsMay 08/b
Analyst Recom3.00Target Price2.00
Avg Volume309.37K52W Range1.46 - 5.52
May-09-24 12:32PM LL Flooring Holdings, Inc. (NYSE:LL) Q1 2024 Earnings Call Transcript (Insider Monkey)
03:02AM LL Flooring Holdings Inc (LL) (Q1 2024) Earnings Call Transcript Highlights: Navigating ... (GuruFocus.com)
May-08-24 06:00AM LL Flooring Reports First Quarter 2024 Financial Results (Business Wire)
Apr-29-24 04:10PM LL Flooring Provides Update on Strategic Alternatives Review (Business Wire)
Apr-25-24 06:30AM LL Flooring to Host First Quarter 2024 Results Call on May 8, 2024 (Business Wire)
Mar-05-24 09:36AM LL Flooring Holdings, Inc. (NYSE:LL) Q4 2023 Earnings Call Transcript (Insider Monkey)
Mar-01-24 04:05PM LL Flooring Reports Fourth Quarter and Full Year 2023 Financial Results (Business Wire)
Feb-26-24 06:45AM LL Flooring to Host Fourth Quarter and Full Year 2023 Results Call on March 4, 2024 (Business Wire)
Jan-29-24 06:30AM Okeefe Stevens Started and Closed its Position in LL Flooring (LL) (Insider Monkey)
Jan-18-24 01:41PM LL Flooring Founder Drops Takeover Offer (Barrons.com)
ALAR - Alarum Technologies Ltd ADR - Stock Price Chart
TickerALAR [NASD]
CompanyAlarum Technologies Ltd ADR
CountryIsrael
IndustrySoftware - Infrastructure
Market Cap232.65MEPS (ttm)-1.40
P/E-EPS this Y935.71%
Forward P/E251.79EPS next Y-88.03%
PEG-EPS past 5Y78.06%
P/S7.96EPS next 5Y-
P/B13.21EPS Q/Q207.75%
Dividend-Sales Q/Q47.49%
Insider Own4.54%Inst Own7.67%
Insider Trans0.00%Inst Trans-28.21%
Short Float5.06%EarningsMay 21/b
Analyst Recom1.00Target Price35.00
Avg Volume297.37K52W Range2.06 - 36.80
May-21-24 12:53PM ALAR Stock Earnings: Alarum Technologies Misses EPS, Beats Revenue for Q1 2024 (InvestorPlace) +12.25%
08:00AM Alarum Announces Q1 2024 Results (GlobeNewswire)
May-06-24 08:30AM Alarum to Release First Quarter 2024 Earnings on May 21, 2024 (GlobeNewswire)
Apr-08-24 08:30AM Alarum Estimates Record Quarterly Revenue of More Than $8.3 Million and All Time High Operating Cashflow of $3.2 Million for the First Quarter of 2024 (GlobeNewswire) +10.07%
Mar-26-24 08:30AM Alarum Announces Exciting Events Lineup and Welcomes Esteemed Advisor to NetNut's Advisory Board (GlobeNewswire) -5.07%
Mar-14-24 07:32AM Alarum Announces Record of $1.7 Million Net Profit and $2.2 Million Adjusted EBITDA in the Fourth Quarter of 2023 (GlobeNewswire) +15.37%
Mar-04-24 08:30AM Alarum to Participate in the 36th Annual Roth Conference (GlobeNewswire)
Feb-29-24 08:30AM Alarum to Release Fourth Quarter and Full Year 2023 Earnings on March 14, 2024 (GlobeNewswire) +6.64%
Feb-21-24 08:30AM Alarum: NetNut to Introduce Revolutionary AI Data Collector Product Line (GlobeNewswire)
Jan-30-24 07:11AM Alarum: NetNut Enhances Data Collection Offering - Launching its Second Innovative Product (GlobeNewswire)
COCH - Envoy Medical Inc - Stock Price Chart
TickerCOCH [NASD]
CompanyEnvoy Medical Inc
CountryUSA
IndustryMedical Devices
Market Cap51.35MEPS (ttm)-0.52
P/E-EPS this Y59.45%
Forward P/E-EPS next Y0.52%
PEG-EPS past 5Y-
P/S223.27EPS next 5Y-
P/B-EPS Q/Q-1992.90%
Dividend-Sales Q/Q-
Insider Own66.94%Inst Own8.43%
Insider Trans0.00%Inst Trans-
Short Float0.54%EarningsMay 15/a
Analyst Recom1.00Target Price5.50
Avg Volume409.00K52W Range0.75 - 11.72
May-15-24 10:53PM COCH Stock Earnings: Envoy Medical Misses EPS, Misses Revenue for Q1 2024 (InvestorPlace)
04:05PM Envoy Medical Reports First Quarter 2024 Results (GlobeNewswire)
Apr-29-24 09:00AM Keynotes, Educational Panels and 96 Companies to Present at the Planet MicroCap Showcase: VEGAS on April 30 - May 2, 2024 at the Paris Hotel & Casino in Las Vegas, NV (ACCESSWIRE) -5.21%
Apr-24-24 08:00AM Envoy Medical to Present at the Planet MicroCap Showcase: Vegas 2024 (GlobeNewswire)
Apr-03-24 08:05AM Envoy Medical to Participate in the LD Micro Invitational XIV Conference April 8 - 9, 2024 (GlobeNewswire) +22.32%
Apr-02-24 10:53PM COCH Stock Earnings: Envoy Medical Beats EPS, Beats Revenue for Q4 2023 (InvestorPlace)
08:00AM Envoy Medical Reports Fourth Quarter and Full Year 2023 Financial Results (GlobeNewswire)
Mar-12-24 10:52AM Envoy Medical to Participate in the 36th Annual ROTH Conference (GlobeNewswire)
Mar-04-24 09:20AM Envoy Medical Secures Up To $10 Million Term Debt Financing to Advance Upcoming Clinical Trial (GlobeNewswire) +39.20%
Feb-07-24 09:00AM Newly Introduced Bipartisan Bill Seeks to Clarify Fully Implanted Active Middle Ear Hearing Devices as Prosthetics, Not Hearing Aids, Making Them Eligible for Medicare Coverage (GlobeNewswire) -16.67%
CUE - Cue Biopharma Inc - Stock Price Chart
TickerCUE [NASD, RUT]
CompanyCue Biopharma Inc
CountryUSA
IndustryBiotechnology
Market Cap78.80MEPS (ttm)-1.07
P/E-EPS this Y12.43%
Forward P/E-EPS next Y0.21%
PEG-EPS past 5Y10.55%
P/S11.22EPS next 5Y-
P/B2.62EPS Q/Q14.99%
Dividend-Sales Q/Q818.18%
Insider Own0.71%Inst Own33.79%
Insider Trans0.00%Inst Trans-6.78%
Short Float9.50%EarningsMay 09/a
Analyst Recom1.00Target Price9.40
Avg Volume281.42K52W Range1.30 - 4.89
May-09-24 11:54PM CUE Stock Earnings: Cue Biopharma Beats EPS, Beats Revenue for Q1 2024 (InvestorPlace)
04:05PM Cue Biopharma Reports First Quarter 2024 Financial Results and Recent Business Highlights (GlobeNewswire)
May-08-24 08:00AM Cue Biopharma to Present at the 20th Annual PEGS Boston Summit (GlobeNewswire) -12.39%
May-07-24 08:00AM Cue Biopharma to Participate in Fireside Chat at The Citizens JMP Life Sciences Conference (GlobeNewswire)
Apr-25-24 09:35AM Here's Why Cue Biopharma (CUE) is Poised for a Turnaround After Losing -22.83% in 4 Weeks (Zacks)
Apr-24-24 10:01AM Cue Biopharma to Present at the 2024 American Society of Clinical Oncology (ASCO) Annual Meeting (GlobeNewswire) -5.33%
Apr-15-24 09:55AM Here's Why Cue Biopharma (CUE) Is a Great 'Buy the Bottom' Stock Now (Zacks) -8.86%
Apr-09-24 07:36AM Q4 2023 Cue Biopharma Inc Earnings Call (Thomson Reuters StreetEvents) -6.86%
03:02AM Cue Biopharma Inc (CUE) Q4 2023 Earnings Call Transcript Highlights: Strategic Alliances and ... (GuruFocus.com)
Apr-08-24 04:05PM Cue Biopharma Reports Fourth Quarter and Full Year 2023 Financial Results and Updated Business Highlights (GlobeNewswire) +10.27%
1⋯10⋯151617181920
affiliate • advertise • toggle light mode • contact • privacy • help
do not sell my data • privacy settings
Quotes delayed 15 minutes for NASDAQ, NYSE and AMEX.
Copyright © 2007-2024 FINVIZ.com. All Rights Reserved.